Smaller, Smarter, Better: Miniaturization and Connectivity in Next-Generation Tubeless Pumps.

3 minutes, 35 seconds Read

The tubeless insulin pump market refers to the market for insulin delivery systems that do not require a traditional tubing system. Tubeless insulin pumps, also known as patch pumps or wearable insulin delivery devices, are designed to provide continuous subcutaneous insulin infusion (CSII) therapy for individuals with diabetes. These pumps consist of a patch-like insulin reservoir and infusion set that adhere directly to the skin, eliminating the need for tubing and allowing for discreet and convenient insulin delivery.

Tubeless insulin pumps offer several advantages over traditional insulin pumps with tubing. They provide greater freedom of movement, allowing individuals to engage in various activities without the limitations of tubing. The patch-like design also offers improved comfort and discretion, as it can be worn discreetly under clothing. Tubeless pumps are typically waterproof, allowing for showering, swimming, and other water-related activities without the need for pump removal.

These pumps are usually controlled wirelessly through a handheld device or smartphone application, allowing for easy programming and dosage adjustments. Some tubeless insulin pumps also feature advanced functionalities such as continuous glucose monitoring (CGM) integration, automated insulin delivery algorithms, and data connectivity for real-time tracking and analysis.

The tubeless insulin pump market has witnessed significant growth in recent years, driven by factors such as the increasing prevalence of diabetes, the demand for advanced insulin delivery solutions, and the desire for improved quality of life for individuals with diabetes. These pumps are particularly beneficial for individuals who require precise insulin dosing, such as those with type 1 diabetes, as well as some individuals with type 2 diabetes.

Key market players

  • Insulet Corporation
  • Johnson & Johnson
  • Medtrum Technologies, Inc.
  • Roche Holding AG
  • Cellnovo Group SA
  • Spring Health Solution Ltd.
  • Debiotech SA
  • CeQur SA
  • Valeritas Holdings, Inc.
  • Abbott Diabetes Care, Inc.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

The tubeless insulin pump market can be segmented based on various factors. Here are some common segmentation approaches:

Product Type:

  1. Patch Pumps: These are tubeless insulin pumps that consist of a patch-like insulin reservoir and infusion set that adhere directly to the skin. They are typically controlled wirelessly through a handheld device or smartphone application.
  2. Pod Pumps: These tubeless insulin pumps come in a self-contained, disposable pod that includes the insulin reservoir, infusion set, and control mechanism. They are typically applied to the body using adhesive.


  1. Type 1 Diabetes: Tubeless insulin pumps are commonly used by individuals with type 1 diabetes who require continuous subcutaneous insulin infusion (CSII) therapy to manage their condition.
  2. Type 2 Diabetes: While tubeless insulin pumps are more commonly associated with type 1 diabetes, they can also be used by some individuals with type 2 diabetes who require intensive insulin therapy.

Age Group:

  1. Adults: Tubeless insulin pumps are widely used by adult individuals with diabetes who benefit from continuous insulin delivery and the convenience of tubeless systems.
  2. Pediatrics: Some tubeless insulin pumps are specifically designed for children and adolescents with diabetes, considering their unique needs and smaller body sizes.

Distribution Channel:

  1. Retail Pharmacies: Tubeless insulin pumps may be distributed through retail pharmacy channels, where individuals can purchase them directly.
  2. Online Stores: Many tubeless insulin pumps are available for purchase through online platforms, providing convenience and accessibility to individuals.


The tubeless insulin pump market can be segmented based on geographical regions, such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Each region may have unique market dynamics, regulatory frameworks, and adoption rates for tubeless insulin pumps.

Download pdf brochure:

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Related report:

To know more        

Contact Us:


Prophecy Market Insights

📞+1 860 531 2574


🌐 Website-

🌐 Blog-

Follow us on:

LinkedIn | Twitter | Facebook

Your Missed